LGND Sale Disclosure
Zimmermann Martine · SEC Form 4 · Filed Sep 14, 2026
Sale
Calculated transaction value
$342K
Zimmermann Martine Director
LGND
Transaction date
Sep 10, 2026
Public filing date
Sep 14, 2026
Filing lag
Filed 4 days later
LGND daily price context
Close on/before transaction
$289.25
Sep 10, 2026
Close before public filing
$284.47
Sep 11, 2026
Return since public filing
-1.34%
Through Sep 14, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 1,200 shares @ $285
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0002001011-26-000140
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$342K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Ligand Pharmaceuticals Inc LGND Current | Sale | Sep 10, 2026 | $342K |